These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 22187960)

  • 1. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
    Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
    Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
    Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
    Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.
    Seki M; Yoshida K; Shiraishi Y; Shimamura T; Sato Y; Nishimura R; Okuno Y; Chiba K; Tanaka H; Kato K; Kato M; Hanada R; Nomura Y; Park MJ; Ishida T; Oka A; Igarashi T; Miyano S; Hayashi Y; Ogawa S; Takita J
    Cancer Res; 2014 May; 74(10):2742-9. PubMed ID: 24675358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    de Kock L; Druker H; Weber E; Hamel N; Traubici J; Malkin D; Arseneau J; Stewart CJ; Bouron-Dal Soglio D; Priest JR; Foulkes WD
    Hum Pathol; 2015 Jun; 46(6):917-22. PubMed ID: 25836323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
    Hughes CE; Liang J; Paulson V; Wang H
    Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
    [No Abstract]   [Full Text] [Related]  

  • 14. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic DICER1 mutations occur in Wilms tumours.
    Wu MK; Sabbaghian N; Xu B; Addidou-Kalucki S; Bernard C; Zou D; Reeve AE; Eccles MR; Cole C; Choong CS; Charles A; Tan TY; Iglesias DM; Goodyer PR; Foulkes WD
    J Pathol; 2013 Jun; 230(2):154-64. PubMed ID: 23620094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
    Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
    Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigree.
    Fernández-Martínez L; Villegas JA; Santamaría Í; Pitiot AS; Alvarado MG; Fernández S; Torres H; Paredes Á; Blay P; Balbín M
    BMC Cancer; 2017 Feb; 17(1):146. PubMed ID: 28222777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.
    Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA
    Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.